title: [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
authors.affiliation: Urologische Klinik und Poliklinik, Klinikum der Universität München-Grosshadern, München. boris.schlenker@med.uni-muenchen.de
authors.forename: Boris
authors.initials: B
authors.lastname: Schlenker
authors.forename: André-Michael
authors.initials: AM
authors.lastname: Beer
authors.forename: Christian
authors.initials: C
authors.lastname: Gratzke
authors.forename: Derya
authors.initials: D
authors.lastname: Tilki
authors.forename: Michael
authors.initials: M
authors.lastname: Seitz
authors.forename: Christian G
authors.initials: CG
authors.lastname: Stief
authors.forename: Oliver
authors.initials: O
authors.lastname: Reich
mesh_terms: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000465:Algorithms; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016896:Treatment Outcome; D001748:Urinary Bladder Neck Obstruction / Q000188:drug therapy*
chemical_list: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors; D010936:Plant Extracts